Outside of the immediate context of
cancer, antineoplastic therapies are often associated with
cardiopulmonary toxicities and organ compromise which
can be exacerbated by smoking and inhaled illicit drug use,
resulting in adverse health complications and significantly
reduced quality of life outcomes among these survivors